Upgrade to SI Premium - Free Trial

Zimmer Biomet (ZBH) PT Lowered to $90 at Wells Fargo

April 29, 2026 8:23 AM
Wells Fargo analyst Larry Biegelsen lowered the price target on Zimmer Biomet (NYSE: ZBH) to $90.00 (from $98.00) while maintaining a Equal Weight rating.

Categories

Analyst PT Change